Revance Therapeutics (NASDAQ:RVNC) Now Covered by StockNews.com
StockNews.com assumed coverage on shares of Revance Therapeutics (NASDAQ:RVNC – Free Report) in a research note released on Sunday. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, Needham & Company LLC reaffirmed a “hold” rating on shares of Revance Therapeutics in a research report on Friday, January 17th. Nine investment analysts […]
StockNews.com assumed coverage on shares of Revance Therapeutics (NASDAQ:RVNC – Free Report) in a research note released on Sunday. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, Needham & Company LLC reaffirmed a “hold” rating on shares of Revance Therapeutics in a research report on Friday, January 17th. Nine investment analysts […]
